机构:[1]Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology & Visual Sciences Key Lab, Beijing, China研究所眼科研究所首都医科大学附属北京同仁医院首都医科大学附属同仁医院
This work were supported by the Beijing Research Ward ExcellenceProgram, BRWEP2024W172050108 and National Key R&D Program of China, 2022YFC2703600.
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类|4 区医学
小类|4 区生物工程与应用微生物4 区细胞与组织工程4 区细胞生物学
最新[2025]版:
大类|4 区医学
小类|4 区生物工程与应用微生物4 区细胞与组织工程4 区细胞生物学
第一作者:
第一作者机构:[1]Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology & Visual Sciences Key Lab, Beijing, China
通讯作者:
推荐引用方式(GB/T 7714):
Zhang Xin,Li Yang,Jin Zi-Bing,et al.Generation of an induced pluripotent stem cell line BIOi004-A from a patient with autosomal dominant retinitis pigmentosa[J].Stem Cell Research.2025,86:103738.doi:10.1016/j.scr.2025.103738.
APA:
Zhang Xin,Li Yang,Jin Zi-Bing&Zhang Xiao-Hui.(2025).Generation of an induced pluripotent stem cell line BIOi004-A from a patient with autosomal dominant retinitis pigmentosa.Stem Cell Research,86,
MLA:
Zhang Xin,et al."Generation of an induced pluripotent stem cell line BIOi004-A from a patient with autosomal dominant retinitis pigmentosa".Stem Cell Research 86.(2025):103738